# FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

> **NCT06286709** · PHASE2 · RECRUITING · sponsor: **University of Birmingham** · enrollment: 58 (estimated)

## Conditions studied

- Primary Sclerosing Cholangitis
- Inflammatory Bowel Diseases

## Interventions

- **BIOLOGICAL:** Faecal Microbiota Transplant
- **OTHER:** FMT Placebo

## Key facts

- **NCT ID:** NCT06286709
- **Lead sponsor:** University of Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-27
- **Primary completion:** 2026-04-30
- **Final completion:** 2027-02-28
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06286709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06286709, "FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06286709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*